Skip to main content
. 2023 Jul 15;201(2):329–338. doi: 10.1007/s10549-023-07016-9

Table 3.

The distribution of molecular subtypes among “pure” DCIS and DCIS with an invasive component, according to the IHC surrogate markers, calculated and classified in the manner of 2011 St. Gallen recommendations

Subtypes Luminal A Luminal B HER2-negative Luminal B HER2-positive HER2-enriched TPN
n = 357 (100%) n = 110 n = 70 n = 79 n = 78 n = 20
Percentage of all 30.8 19.6 22.1 21.8 5.6 100
Percentage of “pure” DCIS 86 90 89 77 90 86
Percentage of DCIS w/invasion 14 10 11 23 10 14